Based on the provided data, Renin-Angiotensin System Medicine sales in Denmark are forecasted to slightly decline over the next few years. The values in US Dollars PPP per capita are as follows:
- 2024: 7.53
- 2025: 7.49 (-0.53%)
- 2026: 7.44 (-0.67%)
- 2027: 7.40 (-0.54%)
- 2028: 7.36 (-0.54%)
On a compound annual growth rate (CAGR) basis, the average variation per year over the last 5 years is approximately -0.56%.
Moving forward, it will be important to monitor factors that could influence the demand for Renin-Angiotensin System medicines. This includes demographic changes, advancements in alternative therapies, healthcare policy adjustments, and economic conditions in Denmark. These could either mitigate or exacerbate the declining trend.
